Tools

LEADER 02399cam 2200469 a 4500

001 ocn182913266;

003 OCoLC;

005 20141212021433.0;

008 071129s2008 maua b 001 0 eng ;

010 a| 2007049289;

020 a| 9781405175715 :c| $99.96;

020 a| 1405175710;

035 a| (Sirsi) o182913266;

035 a| (OCoLC)182913266;

049 a| NEHH;

245 00 a| Biomarkers in heart disease /c| edited by James A. de Lemos.;

260 a| Malden, MA :b| Blackwell Pub.,c| 2008.;

300 a| xii, 238 pages :b| illustrations ;c| 24 cm.;

336 a| text2| rdacontent;

337 a| unmediated2| rdamedia;

338 a| volume2| rdacarrier;

490 1 a| AHA clinical series;

500 a| "American Heart Association.";

504 a| Includes bibliographical references and index.;

505 0 a| Protocols for diagnosing myocardial infarction -- Troponin and other markers of necrosis for risk stratification in patients with acute coronary syndromes -- Challenges interpreting troponin values -- Natriuretic peptides and inflammatory markers for risk stratification in patients with ischemic heart disease -- Novel markers in patients with suspected acute coronary syndromes -- Use of natriuretic peptides in the diagnosis of heart failure -- Biomarkers for risk stratification in patients with heart failure -- Natriuretic peptides for disease monitoring in patients with chronic heart failure -- C-reactive protein -- Newer markers for population screening: focus on lipoprotein-related markers -- Moving towards personalized medicine.;

650 12 a| Heart Diseasesx| blood.=| ^A1202866;

650 12 a| Heart Diseasesx| diagnosis.=| ^A918621;

650 22 a| Biomarkersx| blood=| ^A1204440;

650 22 a| Predictive Value of Tests.=| ^A931151;

650 22 a| Risk Assessmentx| methods.=| ^A933377;

650 0 a| Biochemical markersx| Diagnostic use.=| ^A160152;

650 0 a| Heartx| Diseasesx| Molecular diagnosis.=| ^A453321;

700 1 a| De Lemos, James A.=| ^A1208419;

710 2 a| American Heart Association.=| ^A11171;

830 0 a| AHA clinical series.=| ^A1034362;

994 a| C0b| NEH;

919 a| BOOK;

096 a| WG 141 B615 2008;

596 a| 4;

998 a| 1579087;

999 a| WG 141 B615 2008w| NLMc| 1i| 31740008136057d| 2/23/2011f| 2/23/2011g| 1l| HSLBKm| HSLp| $124.95r| Ys| Yt| HBKu| 7/1/2008x| BOOKz| HSTACKSo| .STAFF. 0;

Biomarkers in heart disease / edited by James A. de Lemos.

Other author	De Lemos, James A.
Other author	American Heart Association.
Format	Book
Publication Info	Malden, MA : Blackwell Pub., 2008.
Description	xii, 238 pages : illustrations ; 24 cm.
Subjects	Heart Diseases--blood. Heart Diseases--diagnosis. Biomarkers--blood. Predictive Value of Tests. Risk Assessment--methods. Biochemical markers--Diagnostic use. Heart--Diseases. --Molecular diagnosis.

Series	AHA clinical series AHA clinical series. ^A1034362
Contents	Protocols for diagnosing myocardial infarction -- Troponin and other markers of necrosis for risk stratification in patients with acute coronary syndromes -- Challenges interpreting troponin values -- Natriuretic peptides and inflammatory markers for risk stratification in patients with ischemic heart disease -- Novel markers in patients with suspected acute coronary syndromes -- Use of natriuretic peptides in the diagnosis of heart failure -- Biomarkers for risk stratification in patients with heart failure -- Natriuretic peptides for disease monitoring in patients with chronic heart failure -- C-reactive protein -- Newer markers for population screening: focus on lipoprotein-related markers -- Moving towards personalized medicine.
General note	"American Heart Association."
Bibliography note	Includes bibliographical references and index.
LCCN	2007049289
ISBN	9781405175715 :
ISBN	1405175710

Biomarkers in heart disease / edited by James A. de Lemos.

Click here for more information about this title